Author

Dana P. Ascherman

Observed names: D Ascherman, Dana P. Ascherman, Dana Ascherman, Dana P Ascherman

Observed institutions: National Institutes of Health, Harvard University, University of Miami, University of Pittsburgh, Government of the United States of America, National Heart, Lung, and Blood Institute, VA Pittsburgh Healthcare System

ORCID: 0000-0002-1387-0860

Observed ORCID: 0000-0002-1387-0860

OpenAlex ID: A5107925852

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 · Chester V. Oddis, Ann M. Reed, et al. · Arthritis & Rheumatism · 703

Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

2013 · Rohit Aggarwal, Andriy Bandos, et al. · Arthritis & Rheumatology · 281

PDF

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

2023 · Alexander G. S. Oldroyd, Jeffrey P. Callen, et al. · Nature Reviews Rheumatology · 171

CIS Associates with the Interleukin-2 Receptor β Chain and Inhibits Interleukin-2-dependent Signaling

1999 · M. Javad Aman, Thi-Sau Migone, et al. · Journal of Biological Chemistry · 116

Interstitial Lung Disease in Idiopathic Inflammatory Myopathy

2010 · Lesley Ann Saketkoo, Dana P. Ascherman, et al. · Current Rheumatology Reviews · 106

IS10 promotes adjacent deletions at low frequency.

1991 · D E Roberts, D Ascherman, et al. · Genetics · 25

PDF

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab

2016 · Rohit Aggarwal, Chester V. Oddis, et al. · Lara D. Veeken · 21

PDF

Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.

2015 · Consuelo M López De Padilla, Cynthia S Crowson, et al. · PubMed · 13

Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

2023 · Didem Saygin, Hanna Kim, et al. · Lara D. Veeken · 10

PDF

Clinical features, classification, and epidemiology of inflammatory muscle disease

2015 · Chester V. Oddis, Dana P. Ascherman · Elsevier eBooks · 7

Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles

2023 · Hanna Kim, Didem Saygin, et al. · Lara D. Veeken · 6

PDF

The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritis

2026 · Yang Li, Ipsita Dey, et al. · JCI Insight · 2

Severe mononeuritis multiplex after rituximab in IgM‐κ monoclonal gammopathy

2017 · Alexis A. Lizarraga, Karlo J. Lizarraga, et al. · Muscle & Nerve · 2

Single-cell RNA sequencing reveals clonally expanded CD4+ tissue-resident memory T cells in histidyl-tRNA synthetase–induced myositis

2026 · Decheng Li, Daniel P. Reay, et al. · JCI Insight

PDF

Remission Rates and Predictors in Idiopathic Inflammatory Myopathy Subgroups: Insights From a Single-Center Cohort

2026 · Nantakarn Pongtarakulpanit, Sidra Tahir, et al. · The Journal of Rheumatology

Multimodal Integration of Protein Interactomes With Genomic and Molecular Data Discovers Distinct Rheumatoid Arthritis Endotypes

2026 · Javad Rahimikollu, Priyamvada Guha Roy, et al. · Arthritis & Rheumatology

Quantifying Cutaneous Dermatomyositis: A Novel 3D Image–Based Approach

2025 · Nantakarn Pongtarakulpanit, Anuradha Bishnoi, et al. · The Journal of Rheumatology

Dermatomyositis assessment of rash via telemedicine: a prospective study

2025 · Nantakarn Pongtarakulpanit, Anuradha Bishnoi, et al. · Clinical and Experimental Rheumatology

PDF

Performance of the Novel Patient Self-Assessment Tools: Patient Dermatomyositis Rash Severity and Patient Dermatomyositis Rash Mapping

2025 · Nantakarn Pongtarakulpanit, Anuradha Bishnoi, et al. · SSRN Electronic Journal

Works count: 19

Citation count: 1,462

H-index: 9

I10-index: 9